Estaphan, Suzanne
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
Estaphan
First Name
Suzanne
Name
Source
Type
Book Title
Entity type
Person
Access Statement
License Rights
DOI
1 results
Search Results
Now showing 1 - 1 of 1
Publication Open Access The cross-talk between Matrix metalloproteinase-9, RANKL/OPG system and cardiovascular risk factors inovariectomized rat model of postmenopausal osteoporosis(Public Library of Science, 2021) Sabry, Maha; Mostafa, Seham; Kamar, Samaa; Rashed, Laila; Estaphan, SuzanneEpidemiology and pathogenesis of cardiovascular diseases (CVD) and osteoporosis are strikingly overlapping. This study presents matrix metalloproteinase-9 (MMP-9), as a simple molecular link more consistently associated with the pathophysiology of both osteoporosis and CVD risk factors. 40 adult female rats were randomly distributed into 4 groups [control sham-operated, untreated osteoporosis, carvedilol-treated osteoporosis and alendronate-treated osteoporosis]. After 8 weeks, blood samples were collected to estimate Lipid profile (Total cholesterol, HDL, Triglycerides), inflammatory markers (IL-6, TNF alpha, CRP and NO), and Bone turnover markers (BTM) (Alkaline phosphatase, osteocalcin and pyridinoline). The tibias were dissected to estimate MMP-9 and NF-kB gene expression, OPG, RANKL levels and for histological examination. Induction of osteoporosis resulted in a significant elevation in BTM, inflammatory markers and dyslipidemia. MMP-9 was significantly elevated and positively correlated with BTM, inflammation and dyslipidemia markers. Carvedilol and alendronate exerted a bone preservative role and attenuated dyslipidaemia and inflammation in accordance with their respective effect on MMP-9.